Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,016,625
-$18,844 QoQ
Shares Held
4,040
-15.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#2,521
of 4,153 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEEDS INVESTOR LLC holds $7,766,038 across 8 Drug Manufacturers - General names. ABBV ranks #2 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,515 | $3,016,566 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
4,040 | $1,016,625 | |
| 3 | NVS |
Novartis AG
|
6,174 | $967,589 | |
| 4 | JNJ |
Johnson & Johnson
|
3,098 | $786,799 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,502 | $707,007 | |
| 6 | AZN |
Astrazeneca PLC
|
2,548 | $483,151 | |
| 7 | PFE |
Pfizer Inc
|
18,646 | $448,995 | |
| 8 | AMGN |
Amgen Inc
|
937 | $339,306 |
All Filings in ABBV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,016,625 | 4,040 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,035,469 | 4,761 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,078,929 | 4,722 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $372,084 | 1,607 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $296,620 | 1,598 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $344,031 | 1,642 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $349,002 | 1,964 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $407,006 | 2,061 | Shares | Sole | 2024-10-31 | |
| No filing history on record for this holder in this stock. | ||||||